Clinical Trials
71
Active:9
Completed:28
Trial Phases
5 Phases
Early Phase 1:1
Phase 1:6
Phase 2:11
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (56 trials with phase data)• Click on a phase to view related trials
Not Applicable
36 (64.3%)Phase 2
11 (19.6%)Phase 1
6 (10.7%)Early Phase 1
1 (1.8%)phase_1_2
1 (1.8%)Phase 4
1 (1.8%)Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs
Not Applicable
Not yet recruiting
- Conditions
- Endometrial CancerGynecological CancersPancreatic AdenocarcinomaUpper Aerodigestive Tract CarcinomaCervical Cancers
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 260
- Registration Number
- NCT07093593
Evaluation of the Effect of Adapted Physical Activity on the Modification of Lipid Metabolism During Chemotherapy for Metastatic COLorectal Cancer
Phase 2
Not yet recruiting
- Conditions
- Metastatic Colorectal Cancer (CRC)Volunteer Subjects
- Interventions
- Biological: Lipidomic analysesOther: Adapted physical activity program
- First Posted Date
- 2025-04-25
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 54
- Registration Number
- NCT06944548
- Locations
- 🇫🇷
Centre Georges-François Leclerc, Dijon, France
🇫🇷CHU Dijon (clinical investigation centre), Dijon, France
Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.
Not Applicable
Recruiting
- Conditions
- All Types of Metastatic Solid Malignancy1st-line TreatmentExome AnalysisActive File EXOMA2 Study
- First Posted Date
- 2024-08-13
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 80
- Registration Number
- NCT06550687
- Locations
- 🇫🇷
Centre Georges-François Leclerc, Dijon, France
🇫🇷CHU François Mitterand, Dijon, France
Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.
Not Applicable
Not yet recruiting
- Conditions
- Patients With Metastatic Castration-resistant Prostate Cancer
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 35
- Registration Number
- NCT06136377
Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2023-11-01
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 150
- Registration Number
- NCT06111417
- Locations
- 🇫🇷
Centre Georges-François Leclerc, Dijon, France
🇫🇷Institut Rafaël, Levallois-perret, France
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
News
No news found